Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Brooklyn Immunotherapeutics Inc (BTX)

Brooklyn Immunotherapeutics Inc (BTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 490,400
  • Shares Outstanding, K 51,730
  • Annual Sales, $ 5,800 K
  • Annual Income, $ -4,420 K
  • 60-Month Beta 4.77
  • Price/Sales 89.55
  • Price/Cash Flow N/A
  • Price/Book 14.88
Trade BTX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.10
  • Most Recent Earnings N/A on 08/17/21
  • Next Earnings Date 08/20/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 116.12%
  • Historical Volatility 79.10%
  • IV Percentile 1%
  • IV Rank 0.96%
  • IV High 240.39% on 05/06/21
  • IV Low 114.91% on 09/17/21
  • Put/Call Vol Ratio 0.33
  • Today's Volume 724
  • Volume Avg (30-Day) 771
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 4,372
  • Open Int (30-Day) 5,494

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.06
  • Number of Estimates 4
  • High Estimate -0.03
  • Low Estimate -0.09
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +14.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.25 +2.49%
on 09/22/21
13.63 -30.45%
on 09/13/21
-0.93 (-8.93%)
since 08/24/21
3-Month
8.80 +7.73%
on 08/20/21
23.34 -59.38%
on 06/28/21
-8.67 (-47.77%)
since 06/24/21

Most Recent Stories

More News
Brooklyn ImmunoTherapeutics Reports Inducement Grants

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients...

BTX : 9.48 (-5.58%)
Brooklyn ImmunoTherapeutics Appoints Roger Sidhu, M.D. as Chief Medical Officer

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients...

BTX : 9.48 (-5.58%)
Brooklyn ImmunoTherapeutics Provides Highlights of Shareholder Update Call from September 20, 2021

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients...

BTX : 9.48 (-5.58%)
Factor Bioscience Celebrates 10th Anniversary with Grand Opening of ISO Class 7 Cleanroom Facility in Cambridge, Massachusetts

/PRNewswire/ -- Factor Bioscience Inc., a biotechnology company headquartered in , celebrated its tenth anniversary on with the grand opening of its new ISO Class 7 cleanroom facility at its headquarters...

BTX : 9.48 (-5.58%)
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor...

ACOG.VN : 1.350 (-3.57%)
GET.CN : 0.285 (+1.79%)
MYID.VN : 0.370 (unch)
OSS.VN : 0.640 (unch)
TBRD.VN : 5.000 (+2.25%)
VMC.VN : 5.870 (-0.17%)
VST.CN : 0.445 (-1.11%)
WTEQ.CN : 0.105 (-4.55%)
XXII : 2.97 (-4.19%)
AYRO : 3.60 (-1.10%)
BCDA : 3.35 (-6.42%)
BLGO : 0.1835 (+0.27%)
BITF : 4.84 (-3.59%)
BAMM.CN : 0.590 (+1.72%)
BMMJ : 0.4662 (+1.17%)
BCTX : 9.19 (+10.99%)
BCTXW : 4.95 (+23.75%)
BTX : 9.48 (-5.58%)
CURR : 0.7480 (+7.36%)
DN.TO : 0.4100 (+2.50%)
DLTNF : 0.3324 (+7.23%)
SOLO : 3.54 (-0.56%)
ELLXF : 0.0720 (-9.55%)
FRSAF : 0.0101 (-15.83%)
FLGC : 6.90 (+33.72%)
GMETF : 0.2216 (-0.94%)
GBLX : 0.0365 (+7.99%)
GOVX : 4.32 (-1.14%)
GTMS.TO : 9.43 (-0.84%)
GBNH : 7.47 (-0.40%)
IFA.TO : 3.30 (unch)
IFABF : 2.5600 (-9.54%)
INND : 0.0088 (-6.38%)
ILAL : 0.7500 (-7.41%)
ISDR : 25.65 (-4.68%)
KSPN : 16.74 (-0.36%)
MYIDF : 0.2876 (+0.49%)
LEAF.TO : 2.91 (+3.19%)
LEMLF : 1.9900 (-10.36%)
LXXGF : 0.3200 (-2.26%)
LTBR : 4.92 (-4.65%)
MDP.TO : 3.01 (-1.95%)
MEDXF : 2.3600 (-0.42%)
OSSIF : 0.5035 (-0.42%)
ORGS : 4.95 (-1.00%)
PTPI : 1.9500 (+4.28%)
PRPH : 5.08 (-1.55%)
MAPPF : 0.3068 (-3.70%)
PYR : 3.99 (-3.16%)
PYR.TO : 5.04 (-3.45%)
LUKEF : 0.2291 (-0.39%)
RCRT : 3.81 (-1.55%)
RCRTW : 1.3000 (-10.34%)
RIII : 0.0440 (+12.82%)
SPVNF : 1.0509 (-0.86%)
STAF : 2.07 (-3.72%)
SPCB : 1.0300 (+1.98%)
TGCB : 0.7500 (unch)
TEKCF : 0.4175 (-12.11%)
TFFP : 8.03 (-0.99%)
THBRF : 3.9500 (+2.60%)
VENZF : 0.0693 (+4.37%)
VEV : 4.67 (+0.43%)
VSQTF : 0.3552 (+0.03%)
VIRI : 5.20 (-4.94%)
VMAR : 6.45 (-0.92%)
VNRX : 3.25 (+1.56%)
WTEQF : 0.0830 (-5.68%)
WPNDF : 1.0000 (-0.99%)
XSF.CN : 0.200 (unch)
XSHLF : 0.1514 (+1.61%)
ZIVO : 5.45 (+57.97%)
Theragnostics Strengthens Board of Directors with Key Appointments

/PRNewswire/ -- Theragnostics, which is developing molecular radiotherapy for imaging and treating a broad range of cancers, announces today the appointments of Dr and Professor as Non-Executive Directors...

GSK : 38.39 (-2.41%)
NTEC : 9.63 (-12.48%)
MYGN : 33.31 (-4.17%)
BTX : 9.48 (-5.58%)
50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period...

ACOG.VN : 1.350 (-3.57%)
ACER : 2.56 (-0.97%)
ADXN : 9.70 (+1.31%)
AGRX : 1.0300 (unch)
ATGN : 2.0500 (-2.38%)
ABIO : 2.98 (-1.32%)
AUUD : 2.43 (-2.41%)
BASA : 0.3050 (-4.09%)
BMRA : 5.13 (+10.80%)
BKTI : 2.91 (+0.34%)
BSFC : 6.3000 (-1.56%)
DTST : 4.58 (-2.35%)
DCTH : 9.85 (+1.13%)
DMIFF : 0.2478 (+3.25%)
DLPN : 11.54 (-4.63%)
FLUX : 5.70 (-2.81%)
GBNH : 7.47 (-0.40%)
HAVLF : 0.2389 (-3.28%)
ISDR : 25.65 (-4.68%)
INLB : 1.6900 (+5.63%)
KNWN : 2.6375 (-1.95%)
LXXGF : 0.3200 (-2.26%)
MKTY : 8.18 (-2.62%)
MMATF : 13.6500 (-2.15%)
MRVFF : 1.0900 (unch)
NEPH : 9.10 (+4.24%)
NMTC : 4.18 (-1.18%)
NLSP : 2.59 (+1.97%)
OBLG : 2.20 (-1.79%)
PBLA : 2.19 (-4.37%)
POSAF : 0.9800 (-2.00%)
PCSA : 7.90 (+1.41%)
PTIX : 2.07 (+4.55%)
QOEG : 0.0999 (+41.50%)
QIPT : 5.90 (-1.17%)
SNGX : 1.0250 (-1.44%)
STRR : 2.57 (+0.78%)
TGCB : 0.7500 (unch)
VERB : 1.7900 (-3.76%)
WTEQ.CN : 0.105 (-4.55%)
WINT : 1.8900 (-0.53%)
AYRO : 3.60 (-1.10%)
BCTX : 9.19 (+10.99%)
BTX : 9.48 (-5.58%)
HWAL : 1.7520 (unch)
NMRD : 6.10 (+1.84%)
THBRF : 3.9500 (+2.60%)
TRIQ : 0.9399 (-1.06%)
Insights on the Spinal Cord Trauma Treatment Global Market to 2027 - Featuring Acorda Therapeutics, BioTime and Pfizer Among Others

The "Spinal Cord Trauma Treatment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

ACOR : 4.74 (+6.28%)
BTX : 9.48 (-5.58%)
Matthew During, M.D., Ph.D. to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, today...

OVID : 3.45 (unch)
BTX : 9.48 (-5.58%)
Dennis H. Langer, M.D., J.D. to Join the Board of Directors of Brooklyn ImmunoTherapeutics, Inc.

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients with cancer, today...

GSK : 38.39 (-2.41%)
NTEC : 9.63 (-12.48%)
BTX : 9.48 (-5.58%)
MYGN : 33.31 (-4.17%)

Business Summary

Brooklyn ImmunoTherapeutics LLC. is a late clinical-stage biopharmaceutical company. It is focused on IL-2 cytokine-based therapies in treating patients with cancer. Brooklyn ImmunoTherapeutics LLC., formerly known as NTN Buzztime, is based in CARLSBAD, Calif.

See More

Key Turning Points

3rd Resistance Point 10.64
2nd Resistance Point 10.38
1st Resistance Point 9.93
Last Price 9.48
1st Support Level 9.22
2nd Support Level 8.96
3rd Support Level 8.51

See More

52-Week High 80.67
Fibonacci 61.8% 51.23
Fibonacci 50% 42.13
Fibonacci 38.2% 33.03
Last Price 9.48
52-Week Low 3.59

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar